Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-04 @ 11:38 PM
Study NCT ID:
NCT01360593
Status:
COMPLETED
Last Update Posted:
2022-03-08
First Post:
2011-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
Sponsor:
David A. Clump, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-24
First Submit QC Date:
None
Study First Post Date:
2011-05-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-12-16
Results First Submit QC Date:
None
Results First Post Date:
2022-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-10
Last Update Post Date:
2022-03-08
Last Update Post Date Type:
ACTUAL